Compare WELL & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WELL | DHR |
|---|---|---|
| Founded | 1970 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.1B | 148.8B |
| IPO Year | N/A | N/A |
| Metric | WELL | DHR |
|---|---|---|
| Price | $190.49 | $226.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 18 |
| Target Price | $203.90 | ★ $247.88 |
| AVG Volume (30 Days) | 3.6M | ★ 3.7M |
| Earning Date | 10-27-2025 | 01-28-2026 |
| Dividend Yield | ★ 1.58% | 0.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.46 | ★ 4.87 |
| Revenue | $9,907,853,000.00 | ★ $24,268,000,000.00 |
| Revenue This Year | $30.93 | $3.72 |
| Revenue Next Year | $17.66 | $3.99 |
| P/E Ratio | $127.98 | ★ $46.51 |
| Revenue Growth | ★ 32.28 | 2.21 |
| 52 Week Low | $123.11 | $171.00 |
| 52 Week High | $209.05 | $258.23 |
| Indicator | WELL | DHR |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 54.36 |
| Support Level | $183.60 | $223.19 |
| Resistance Level | $205.55 | $232.82 |
| Average True Range (ATR) | 4.18 | 4.25 |
| MACD | -2.68 | -0.45 |
| Stochastic Oscillator | 26.84 | 34.79 |
Welltower owns a diversified healthcare portfolio of 2,391 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.